Financhill
Back

Regeneron Pharmaceuticals Vs. Biogen Industry Stock Comparison

Sell
37

REGN
Regeneron Pharmaceuticals

Last Price:
829.32
Seasonality Move:
11.8%
Sell
38

BIIB
Biogen

Last Price:
176.91
Seasonality Move:
5.71%
Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $829.43. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $176.93. The Score for BIIB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $829.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $176.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -57.31 Sell
Relative Strength Index (14 RSI): 13.94 Sell
Chaikin Money Flow: 109670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (895.28 - 1026.78) Sell
Bollinger Bands (100): (983.53 - 1152.51) Sell

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.62 Sell
Relative Strength Index (14 RSI): 36.68 Sell
Chaikin Money Flow: 2223401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (179.1 - 189.5) Sell
Bollinger Bands (100): (188.18 - 221.74) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 881.48 Sell
20-day SMA: 945.74 Sell
50-day SMA: 1047.97 Sell
200-day SMA: 1011.95 Sell
8-day EMA: 873.49 Sell
20-day EMA: 932.64 Sell
50-day EMA: 1004.92 Sell
200-day EMA: 999.95 Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 178.7 Sell
20-day SMA: 183.71 Sell
50-day SMA: 191.83 Sell
200-day SMA: 213.36 Sell
8-day EMA: 178.17 Sell
20-day EMA: 182.75 Sell
50-day EMA: 190.81 Sell
200-day EMA: 213.07 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $0.75 per share.

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.43 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):